Safety of Live-attenuated Influenza Vaccine (LAIV, Flumist) in Patients With Cystic Fibrosis (CF)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2014
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 15 Sep 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 15 Sep 2014 Planned End Date changed from 1 Mar 2016 to 1 Dec 2015 as reported by ClinicalTrials.gov record.